Allergies
are medical conditions triggered by reactions to various substances such as
pollen, dust, weeds, and others. They are physically characterized by spots on
the skin, coughing, and other symptoms. Allergy skin tests are a trustworthy
option for ascertaining the presence of allergies in a patient. The global Allergy
Diagnostics Market Size report by Market Research Future (MRFR) lists out
drivers, trends, and challenges in a detailed and comprehensive manner.
Market Overview
The
Global Allergy Diagnostics Market Size is touted to attain a significant valuation
at a CAGR of 8.2% during the forecast period (2017-2023). High reported cases
of allergies such as asthma, allergic conjunctivitis, and rhinitis is one of
the primary drivers of the market. According to the World Health Organization
(WHO), close to 40 million cases of allergies related to inhalation have been
reported in 2012. Large number of patients with allergies due to consumption of
drugs and massive demand for allergy tests are other drivers expected to augur
well for the market growth.
Availability
of diagnostics and therapeutics at major hospitals is estimated to widen the
scope of the market till 2023. Accuracy and reliability of these tests can
foster the market growth. Change in lifestyles, poor dietary habits, increasing
levels of indoor and outdoor pollution, and rapid urbanization can influence
the market growth. Introduction of specific allergen in the tests to enhance
its accuracy can do wonders for the global Allergy Diagnostics Market Size.
Segmentation
The
global Allergy Diagnostics Market Size is segmented by type, indication, and
end-user.
By
type, it is segmented into patch, intradermal, prick, and others.
By
indication, it is segmented into urticarial, anaphylaxis, allergy rhinitis,
allergy conjunctivitis, drug allergy, and others.
By
end-user, it is segmented into diagnostic centers, hospitals & clinics, and
others.
Regional Analysis
The
Middle East & Africa (MEA), Europe, Asia Pacific (APAC), and the Americas
are the main regions considered during the compilation of the market report.
Europe
is the biggest and most lucrative region for the global Allergy Diagnostics
Market Size due to prevalence of anaphylaxis and demand for rapid diagnostic
services. The market will thrive due to high cases of allergies being reported.
As per European Academy of Allergy and Clinical Immunology, nearly 150 million
in the European Union (EU) suffer from some form of allergic disease.
The
Americas held close to 30% market share in 2016. It can experience a massive
upheaval in demand due to rise in the cases of allergies in the U.S. According
to the American College of Allergy Asthma and Immunology, eczema, food allergy,
and allergic asthma are the most common types found in the region. The
availability of technologically advanced tests to ascertain their presence at a
preventive stage can bode well for the market.
The
APAC region can display a strong CAGR during the forecast timespan due to high
prevalence of allergic asthma due to rise in pollution levels. Other factors
which can influence the sales of allergy skin tests are availability of
portable devices and mobile applications which can lower the price of the
product by a considerable degree. Presence of minimally invasive diagnostic
techniques, unmet patient needs, and improvement in the healthcare
infrastructure can bode well for the market growth.
The
MEA region can exhibit a modest rise in demand for allergy skin tests due to
high incidence of chronic respiratory diseases.
Competition Outlook
Lincoln
Diagnostics, Inc., Cell Science Systems, Novartis Global, Quest Diagnostics
Incorporated, HollisterStier Allergy, Thermo Fisher Scientific, and Arlington
Scientific, Inc., are prominent names in the global Allergy Diagnostics Market
Size. Innovation in products and services as well as changes in the supply
chain are taken into consideration by these players for accelerating the
production rate and getting the product faster to clients.
Industry News
The
Colourstart test has been approved by the Medicines and Healthcare products
Regulatory Agency (MHRA) in the U.K. to be sold for teens starting from the age
of 16. The test contains two skin patches which can be used to discern an
allergic reaction to hair dye which contains the chemical, paraphenylenediamine
(PPD).
No comments:
Post a Comment